| Year |
Citation |
Score |
| 2024 |
van Rheede JJ, Alagapan S, Denison TJ, Riva-Posse P, Rozell CJ, Mayberg HS, Waters AC, Sharott A. Cortical signatures of sleep are altered following effective deep brain stimulation for depression. Translational Psychiatry. 14: 103. PMID 38378677 DOI: 10.1038/s41398-024-02816-z |
0.479 |
|
| 2023 |
Xu E, Pitts S, Dahill-Fuchel J, Scherrer S, Nauvel T, Overton JG, Riva-Posse P, Crowell A, Figee M, Alagapan S, Rozell C, Choi KS, Mayberg HS, Waters AC. Neural Interoceptive Processing is Modulated by Deep Brain Stimulation for Treatment Resistant Depression. Biorxiv : the Preprint Server For Biology. PMID 38187733 DOI: 10.1101/2023.12.15.571885 |
0.67 |
|
| 2023 |
Loo C, Glozier N, Barton D, Baune BT, Mills NT, Fitzgerald P, Glue P, Sarma S, Galvez-Ortiz V, Hadzi-Pavlovic D, Alonzo A, Dong V, Martin D, Nikolin S, Mitchell PB, ... ... Riva-Posse P, et al. Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial. The British Journal of Psychiatry : the Journal of Mental Science. 223: 533-541. PMID 38108319 DOI: 10.1192/bjp.2023.79 |
0.315 |
|
| 2023 |
Cha J, Choi KS, Rajendra JK, McGrath CL, Riva-Posse P, Holtzheimer PE, Figee M, Kopell BH, Mayberg HS. Whole brain network effects of subcallosal cingulate deep brain stimulation for treatment-resistant depression. Molecular Psychiatry. PMID 37919403 DOI: 10.1038/s41380-023-02306-6 |
0.615 |
|
| 2023 |
Alagapan S, Choi KS, Heisig S, Riva-Posse P, Crowell A, Tiruvadi V, Obatusin M, Veerakumar A, Waters AC, Gross RE, Quinn S, Denison L, O'Shaughnessy M, Connor M, Canal G, et al. Cingulate dynamics track depression recovery with deep brain stimulation. Nature. PMID 37730990 DOI: 10.1038/s41586-023-06541-3 |
0.699 |
|
| 2023 |
Benjamin I, Hershenberg R, Dorrell KD, Tan AC, Riva-Posse P, McDonald WM, Hermida AP, Crowell A, Feinstein BA. Differences in clinical presentations of patients seeking care for treatment-resistant depression across sexual orientations and gender identities. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 35: 199-208. PMID 37459501 DOI: 10.12788/acp.0112 |
0.337 |
|
| 2023 |
Cha J, Rajendra JJ, McGrath C, Riva-Posse P, Holtzheimer P, Mayberg H, Choi KS. Whole Brain Network effects of subcallosal cingulate deep brain stimulation for treatment-resistant depression. Research Square. PMID 37398243 DOI: 10.21203/rs.3.rs-3025802/v1 |
0.615 |
|
| 2023 |
Singh B, Vande Voort JL, Riva-Posse P, Pazdernik VM, Frye MA, Tye SJ. Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant Depression. Biological Psychiatry. PMID 36707268 DOI: 10.1016/j.biopsych.2022.10.007 |
0.335 |
|
| 2022 |
Tiruvadi V, James S, Howell B, Obatusin M, Crowell A, Riva-Posse P, Gross RE, McIntyre CC, Mayberg HS, Butera R. Mitigating Mismatch Compression in Differential Local Field Potentials. Ieee Transactions On Neural Systems and Rehabilitation Engineering : a Publication of the Ieee Engineering in Medicine and Biology Society. PMID 36288215 DOI: 10.1109/TNSRE.2022.3217469 |
0.633 |
|
| 2022 |
Smith EE, Choi KS, Veerakumar A, Obatusin M, Howell B, Smith AH, Tiruvadi V, Crowell AL, Riva-Posse P, Alagapan S, Rozell CJ, Mayberg HS, Waters AC. Time-frequency signatures evoked by single-pulse deep brain stimulation to the subcallosal cingulate. Frontiers in Human Neuroscience. 16: 939258. PMID 36061500 DOI: 10.3389/fnhum.2022.939258 |
0.541 |
|
| 2022 |
Figee M, Riva-Posse P, Choi KS, Bederson L, Mayberg HS, Kopell BH. Deep Brain Stimulation for Depression. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 35817944 DOI: 10.1007/s13311-022-01270-3 |
0.665 |
|
| 2021 |
Sendi MSE, Waters AC, Tiruvadi V, Riva-Posse P, Crowell A, Isbaine F, Gale JT, Choi KS, Gross RE, S Mayberg H, Mahmoudi B. Intraoperative neural signals predict rapid antidepressant effects of deep brain stimulation. Translational Psychiatry. 11: 551. PMID 34728599 DOI: 10.1038/s41398-021-01669-0 |
0.605 |
|
| 2021 |
Youssef NA, Dela Cruz SAMF, Riva-Posse P, Patel RS. Characteristics of patients who had deep brain stimulation for treatment-resistant depression from among 116,890 inpatients with major depressive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 33: 251-257. PMID 34672927 DOI: 10.12788/acp.0045 |
0.513 |
|
| 2021 |
Dandekar MP, Diaz AP, Rahman Z, Silva RH, Nahas Z, Aaronson S, Selvaraj S, Fenoy AJ, Sanches M, Soares JC, Riva-Posse P, Quevedo J. A narrative review on invasive brain stimulation for treatment-resistant depression. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 34468549 DOI: 10.1590/1516-4446-2021-1874 |
0.51 |
|
| 2021 |
Parikh SV, Lopez D, Vande Voort JL, Rico J, Achtyes E, Coryell W, Goddard A, Goes F, Greden JF, Singh B, Kaplin A, Frye MA, Maixner D, Watson B, Drake K, ... ... Riva-Posse P, et al. Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer. Psychopharmacology Bulletin. 51: 109-124. PMID 34421148 |
0.3 |
|
| 2021 |
Dini H, Sendi MSE, Sui J, Fu Z, Espinoza R, Narr KL, Qi S, Abbott CC, van Rooij SJH, Riva-Posse P, Bruni LE, Mayberg HS, Calhoun VD. Dynamic Functional Connectivity Predicts Treatment Response to Electroconvulsive Therapy in Major Depressive Disorder. Frontiers in Human Neuroscience. 15: 689488. PMID 34295231 DOI: 10.3389/fnhum.2021.689488 |
0.536 |
|
| 2021 |
Hu Y, Kung S, Ozerdem A, Vande Voort J, Singh B, McDonald WM, Riva-Posse P, Frye MA. Hypomania Associated with High Dose Ketamine Treatment. Bipolar Disorders. PMID 33587793 DOI: 10.1111/bdi.13059 |
0.307 |
|
| 2020 |
van Rooij SJH, Riva-Posse P, McDonald WM. The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression. Current Treatment Options in Psychiatry. 7: 337-348. PMID 33585164 DOI: 10.1007/S40501-020-00216-W |
0.436 |
|
| 2020 |
Bobo WV, Riva-Posse P, Goes FS, Parikh SV. Next-Step Treatment Considerations for Patients With Treatment-Resistant Depression That Responds to Low-Dose Intravenous Ketamine. Focus (American Psychiatric Publishing). 18: 181-192. PMID 33162856 DOI: 10.1176/appi.focus.20190048 |
0.373 |
|
| 2020 |
McCall MV, Riva-Posse P, Garlow SJ, Mayberg HS, Crowell AL. Analyzing Non-verbal Behavior Throughout Recovery in a Sample of Depressed Patients Receiving Deep Brain Stimulation. Neurology, Psychiatry, and Brain Research. 37: 33-40. PMID 32699489 DOI: 10.1016/J.Npbr.2020.05.002 |
0.638 |
|
| 2020 |
Riva-Posse P, Crowell AL, Wright K, Waters AC, Choi K, Garlow SJ, Holtzheimer PE, Gross RE, Mayberg HS. Rapid Antidepressant Effects of Deep Brain Stimulation and Their Relation to Surgical Protocol. Biological Psychiatry. PMID 32418613 DOI: 10.1016/J.Biopsych.2020.03.017 |
0.689 |
|
| 2020 |
Riva-Posse P. Why is deep brain stimulation for treatment-resistant depression a needed treatment option? Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 42: 344-346. PMID 32401869 DOI: 10.1590/1516-4446-2020-0004 |
0.592 |
|
| 2020 |
Miocinovic S, Ostrem JL, Okun MS, Bullinger KL, Riva-Posse P, Gross RE, Buetefisch CM. Recommendations for Deep Brain Stimulation Device Management During a Pandemic. Journal of Parkinson's Disease. PMID 32333552 DOI: 10.3233/Jpd-202072 |
0.529 |
|
| 2020 |
Hershenberg R, McDonald WM, Crowell A, Riva-Posse P, Craighead WE, Mayberg HS, Dunlop BW. Concordance between clinician-rated and patient reported outcome measures of depressive symptoms in treatment resistant depression. Journal of Affective Disorders. 266: 22-29. PMID 32056880 DOI: 10.1016/J.Jad.2020.01.108 |
0.597 |
|
| 2020 |
Ahmed AT, MahmoudianDehkordi S, Bhattacharyya S, Arnold M, Liu D, Neavin D, Moseley MA, Thompson JW, Williams LSJ, Louie G, Skime MK, Wang L, Riva-Posse P, McDonald WM, Bobo WV, et al. Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes. Journal of Affective Disorders. 264: 90-97. PMID 32056779 DOI: 10.1016/J.Jad.2019.11.122 |
0.454 |
|
| 2020 |
Hermida AP, Petrides G, Lapid M, Nykamp L, Chapman H, McDonald W, Riva-Posse P, Lunceford A, Sanghani S, Seiner S, Harper D, Rahman A, Kilpatrick E, Sutor B, Johnson E, et al. TREATMENT PARAMETERS AND RATIONALE FOR THE USE OF ELECTROCONVULSIVE THERAPY FOR THE MANAGEMENT OF TREATMENT-REFRACTORY AGITATION IN ALZHEIMER'S DISEASE The American Journal of Geriatric Psychiatry. 28: S144-S145. DOI: 10.1016/J.Jagp.2020.01.177 |
0.343 |
|
| 2020 |
Hermida AP, Dhingra A, Chapman H, Lunceford A, Janjua AU, Job G, Riva-Posse P, Tan A, McDonald W. RIGHT UNILATERAL ELECTROCONVULSIVE THERAPY FOR THE TREATMENT OF LATE-LIFE BIPOLAR DISORDER The American Journal of Geriatric Psychiatry. 28: S143-S144. DOI: 10.1016/J.Jagp.2020.01.176 |
0.412 |
|
| 2020 |
Waters A, Scherrer S, Obatusin M, Veerakumar A, Riva-Posse P, Crowell A, O'Neill S, Mayberg H. Effect of Deep Brain Stimulation for Treatment Resistant Depression on Interoceptive Processing: A Pilot Study of the Heartbeat Evoked Potential as Biomarker of Treatment Efficacy Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.991 |
0.694 |
|
| 2020 |
Waters A, Smith EE, Choi KS, Veerakumar A, Obatusin M, Crowell A, Riva-Posse P, Figee M, Mayberg H. Perturbation-Based Mapping of Subcallosal Cingulate With Deep Brain Stimulation: Cortical Oscillatory Dynamics to Confirm Target for Electrical Neuromodulation Biological Psychiatry. 87: S320-S321. DOI: 10.1016/J.Biopsych.2020.02.824 |
0.598 |
|
| 2020 |
Alagapan S, Waters A, Veerakumar A, Obatusin M, Tiruvadi V, Crowell A, Riva-Posse P, Butera R, Mayberg H, Rozell C. Longitudinal Changes in Subcallosal Cingulate Local Field Potential Features in Patients Undergoing DBS for Treatment-Resistant Depression Biological Psychiatry. 87: S193. DOI: 10.1016/J.Biopsych.2020.02.503 |
0.609 |
|
| 2020 |
Riva-Posse P, Waters A, Choi KS, Crowell A, Wright K, Mayberg H. Improved Rapid Effects of Deep Brain Stimulation in the Subcallosal Cingulate Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.487 |
0.637 |
|
| 2020 |
Waters A, Choi K, Veerakumar A, Obatusin M, Riva-Posse P, Crowell A, Mayberg H. Individual Differences in the Cortical Response to Deep Brain Stimulation for Treatment Resistant Depression Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.141 |
0.703 |
|
| 2019 |
Riva-Posse P, Holtzheimer PE, Mayberg HS. Cingulate-mediated depressive symptoms in neurologic disease and therapeutics. Handbook of Clinical Neurology. 166: 371-379. PMID 31731923 DOI: 10.1016/B978-0-444-64196-0.00021-2 |
0.629 |
|
| 2019 |
Crowell AL, Riva-Posse P, Holtzheimer PE, Garlow SJ, Kelley ME, Gross RE, Denison L, Quinn S, Mayberg HS. Long-Term Outcomes of Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression. The American Journal of Psychiatry. appiajp201918121427. PMID 31581800 DOI: 10.1176/Appi.Ajp.2019.18121427 |
0.737 |
|
| 2019 |
Riva-Posse P, Inman CS, Choi KS, Crowell AL, Gross RE, Hamann S, Mayberg HS. Autonomic arousal elicited by subcallosal cingulate stimulation is explained by white matter connectivity. Brain Stimulation. PMID 30738778 DOI: 10.1016/J.Brs.2019.01.015 |
0.709 |
|
| 2019 |
Janjua A, Hack L, Dover S, Job G, McDonald W, Riva-Posse P. Predicting transcranial magnetic stimulation response with machine learning in a treatment resistant depression population Brain Stimulation. 12: 512-513. DOI: 10.1016/J.Brs.2018.12.682 |
0.43 |
|
| 2018 |
Waters AC, Veerakumar A, Choi KS, Howell B, Tiruvadi V, Bijanki KR, Crowell A, Riva-Posse P, Mayberg HS. Test-retest reliability of a stimulation-locked evoked response to deep brain stimulation in subcallosal cingulate for treatment resistant depression. Human Brain Mapping. PMID 30120851 DOI: 10.1002/hbm.24327 |
0.642 |
|
| 2018 |
Smart O, Choi KS, Riva-Posse P, Tiruvadi V, Rajendra J, Waters AC, Crowell AL, Edwards J, Gross RE, Mayberg HS. Initial Unilateral Exposure to Deep Brain Stimulation in Treatment-Resistant Depression Patients Alters Spectral Power in the Subcallosal Cingulate. Frontiers in Computational Neuroscience. 12: 43. PMID 29950982 DOI: 10.3389/Fncom.2018.00043 |
0.694 |
|
| 2018 |
Ahmed AT, Frye MA, Rush AJ, Biernacka JM, Craighead WE, McDonald WM, Bobo WV, Riva-Posse P, Tye SJ, Mayberg HS, Flavin DH, Skime MK, Jenkins GD, Wang L, Krishnan RR, et al. Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders. Journal of Affective Disorders. 238: 1-7. PMID 29807322 DOI: 10.1016/J.Jad.2018.05.005 |
0.496 |
|
| 2018 |
Riva-Posse P, Reiff CR, Edwards JA, Job GP, Galendez GC, Garlow SJ, Saah TC, Dunlop BW, McDonald WM. Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions. Journal of Affective Disorders. PMID 29525051 DOI: 10.1016/J.Jad.2018.02.025 |
0.4 |
|
| 2018 |
Bari AA, Mikell CB, Abosch A, Ben-Haim S, Buchanan RJ, Burton AW, Carcieri S, Cosgrove GR, D'Haese PF, Daskalakis ZJ, Eskandar EN, Gerrard JL, Goodman WK, Greenberg BD, Gross RE, ... ... Riva-Posse P, et al. Charting the road forward in psychiatric neurosurgery: proceedings of the 2016 American Society for Stereotactic and Functional Neurosurgery workshop on neuromodulation for psychiatric disorders. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29371415 DOI: 10.1136/Jnnp-2017-317082 |
0.642 |
|
| 2018 |
Crowell AL, Riva-Posse P. Consent for Deep Brain Stimulation in Depression: A Perspective From Investigators Ajob Neuroscience. 9: 237-239. DOI: 10.1080/21507740.2018.1553904 |
0.602 |
|
| 2018 |
Crowell A, Denison L, Riva-Posse P, Mayberg H. F86. Durability of Response to Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.699 |
0.68 |
|
| 2017 |
Choi KS, Noecker AM, Riva-Posse P, Rajendra JK, Gross RE, Mayberg HS, McIntyre CC. Impact of brain shift on subcallosal cingulate deep brain stimulation. Brain Stimulation. PMID 29246748 DOI: 10.1016/J.Brs.2017.12.001 |
0.719 |
|
| 2017 |
Medeiros da Frota Ribeiro C, Riva-Posse P. Use of Ketamine in Elderly Patients with Treatment-Resistant Depression. Current Psychiatry Reports. 19: 107. PMID 29138992 DOI: 10.1007/S11920-017-0855-X |
0.493 |
|
| 2017 |
Noecker AM, Choi KS, Riva-Posse P, Gross RE, Mayberg HS, McIntyre CC. StimVision Software: Examples and Applications in Subcallosal Cingulate Deep Brain Stimulation for Depression. Neuromodulation : Journal of the International Neuromodulation Society. PMID 28653482 DOI: 10.1111/ner.12625 |
0.688 |
|
| 2017 |
Riva-Posse P, Choi KS, Holtzheimer PE, Crowell AL, Garlow SJ, Rajendra JK, McIntyre CC, Gross RE, Mayberg HS. A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression. Molecular Psychiatry. PMID 28397839 DOI: 10.1038/Mp.2017.59 |
0.649 |
|
| 2017 |
Tiruvadi VR, Veerakumar A, Crowell A, Waters A, Butera R, Riva-Posse P, Mayberg H. Electrophysiologic signatures of SCC-DBS efficacy Brain Stimulation. 10: 501. DOI: 10.1016/J.Brs.2017.01.464 |
0.499 |
|
| 2017 |
Riva-Posse P, Choi K, Crowell A, Gross R, Mayberg H. Target selection in subcallosal cingulate deep brain stimulation: a prospective, connectomic-based method Brain Stimulation. 10: 482. DOI: 10.1016/J.Brs.2017.01.410 |
0.578 |
|
| 2016 |
Mayberg HS, Riva-Posse P, Crowell AL. Deep Brain Stimulation for Depression: Keeping an Eye on a Moving Target. Jama Psychiatry. PMID 27049731 DOI: 10.1001/Jamapsychiatry.2016.0173 |
0.626 |
|
| 2015 |
Choi KS, Riva-Posse P, Gross RE, Mayberg HS. Mapping the "Depression Switch" During Intraoperative Testing of Subcallosal Cingulate Deep Brain Stimulation. Jama Neurology. 72: 1252-60. PMID 26408865 DOI: 10.1001/Jamaneurol.2015.2564 |
0.717 |
|
| 2015 |
Crowell AL, Garlow SJ, Riva-Posse P, Mayberg HS. Characterizing the therapeutic response to deep brain stimulation for treatment-resistant depression: a single center long-term perspective. Frontiers in Integrative Neuroscience. 9: 41. PMID 26124710 DOI: 10.3389/Fnint.2015.00041 |
0.668 |
|
| 2014 |
Riva-Posse P, Choi KS, Holtzheimer PE, McIntyre CC, Gross RE, Chaturvedi A, Crowell AL, Garlow SJ, Rajendra JK, Mayberg HS. Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression. Biological Psychiatry. 76: 963-9. PMID 24832866 DOI: 10.1016/J.Biopsych.2014.03.029 |
0.722 |
|
| 2014 |
Sultan R, Riva-Posse P, Garlow SJ, Schwartz AC. Beneficial pre-ECT ketamine infusion in a patient with treatment-resistant depression. Psychosomatics. 55: 396-9. PMID 24735865 DOI: 10.1016/J.Psym.2013.12.002 |
0.356 |
|
| 2014 |
Crowell AL, Riva-Posse P, Garlow SJ, Mayberg HS. Toward an Understanding of the Neural Circuitry of Major Depressive Disorder Through the Clinical Response to Deep Brain Stimulation of Different Anatomical Targets Current Behavioral Neuroscience Reports. 1: 55-63. DOI: 10.1007/S40473-014-0008-Z |
0.589 |
|
| 2013 |
Riva-Posse P, Hermida AP, McDonald WM. The role of electroconvulsive and neuromodulation therapies in the treatment of geriatric depression. The Psychiatric Clinics of North America. 36: 607-30. PMID 24229660 DOI: 10.1016/J.Psc.2013.08.007 |
0.46 |
|
| 2013 |
Riva-Posse P, Holtzheimer PE, Garlow SJ, Mayberg HS. Practical considerations in the development and refinement of subcallosal cingulate white matter deep brain stimulation for treatment-resistant depression. World Neurosurgery. 80: S27.e25-34. PMID 23246630 DOI: 10.1016/J.Wneu.2012.11.074 |
0.708 |
|
| Show low-probability matches. |